TOPARP: A Phase II Trial of Olaparib in Patients With Advanced Castration Resistant Prostate Cancer (TOPARP)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01682772 |
Recruitment Status : Unknown
Verified August 2019 by Institute of Cancer Research, United Kingdom.
Recruitment status was: Active, not recruiting
First Posted : September 11, 2012
Last Update Posted : August 15, 2019
|
Sponsor:
Institute of Cancer Research, United Kingdom
Collaborator:
Royal Marsden NHS Foundation Trust
Information provided by (Responsible Party):
Institute of Cancer Research, United Kingdom
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Unknown |
---|---|
Actual Primary Completion Date : | March 2019 |
Estimated Study Completion Date : | February 2020 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):